Creative Medical Technology Holdings, Inc. (CELZ) — Financial statements
Income statement, balance sheet, and cash flow for Creative Medical Technology Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.01↓45.5% | 0.01↑22.2% | 0.01↓89.8% | 0.09↑1.0% | 0.09 | |
| Cost of Revenue | 0.13↑2752.8% | 0.00↑22.2% | 0.00↓87.4% | 0.03↓40.6% | 0.05 | |
| Gross Profit | -0.12↓1910.9% | 0.01↑22.2% | 0.01↓91.0% | 0.06↑51.0% | 0.04 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↓5.9% | 2↑21.8% | 2↓68.6% | 6↑5641.8% | 0.11 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 4↑16.2% | 3↓9.0% | 4↓9.7% | 4↑33.0% | 3 | |
| Other Expenses | 0.00↓100.0% | 0.11↑16.8% | 0.09↑2.7% | 0.09↑0.0% | 0.09 | |
| Operating Expenses | 6↑4.7% | 6↑2.2% | 6↓45.4% | 10↑225.5% | 3 | |
| Total Costs & Expenses | 6↑6.8% | 6↑2.2% | 6↓45.5% | 10↑221.5% | 3 | |
| Operating Results | ||||||
| Operating Income | -6↓6.9% | -6↓2.2% | -6↑45.1% | -10↓227.7% | -3 | |
| Depreciation & Amortization | 0.12↑11.7% | 0.11↑16.8% | 0.09↑2.7% | 0.09↑0.0% | 0.09 | |
| EBITDA | -6↓6.9% | -6↓2.0% | -6↑45.6% | -10↓143.1% | 24 | |
| EBIT | -6↓6.9% | -6↓2.2% | -6↑45.1% | -10↓143.6% | 23 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.15↓41.0% | 0.25↓24.9% | 0.33↑232.5% | 0.10↑102.3% | -4 | |
| Interest Income | 0.15↓41.0% | 0.25↓24.9% | 0.33↑232.5% | 0.10 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 4 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -27 | |
| Other Income / Expenses | 0.15↓41.0% | 0.25↓24.9% | 0.33↑232.5% | 0.10↓99.6% | 22 | |
| Income Before Tax | -6↓9.1% | -5↓3.9% | -5↑47.9% | -10↓152.8% | 19 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -6↓9.1% | -5↓3.9% | -5↑47.9% | -10↓152.8% | 19 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -6↓9.1% | -5↓3.9% | -5↑47.9% | -10↓152.8% | 19 | |
| Bottom-Line Net Income | -6↓9.1% | -5↓3.9% | -5↑47.9% | -10↓152.8% | 19 | |
| EPS (Basic) | -2.52↑32.1% | -3.71↑1.3% | -3.76↑59.5% | -9.28↓112.6% | 73.75 | |
| EPS (Diluted) | -2.52↑32.1% | -3.71↑1.3% | -3.76↑59.5% | -9.28↓116.5% | 56.10 | |
| Weighted Average Shares | 2↑61.0% | 1↑5.2% | 1↑28.8% | 1↑319.6% | 0.26 | |
| Weighted Average Diluted Shares | 2↑61.0% | 1↑5.2% | 1↑28.8% | 1↑236.5% | 0.32 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.